Litcius/Paper detail

Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis

Marco Senzolo, Salvatore Piano, Sarah Shalaby, Marta Tonon, S. Tonello, Alberto Zanetto, David Sacerdoti, Paolo Simioni, Giancarlo Bombonato, Patrizia Burra, Paolo Angeli

2021The American Journal of Medicine24 citationsDOI

Topics & Concepts

MedicineThrombosisPortal vein thrombosisFondaparinuxCirrhosisSurgeryHeparinInternal medicineVenous thromboembolismLiver Disease and TransplantationVenous Thromboembolism Diagnosis and ManagementHepatocellular Carcinoma Treatment and Prognosis
Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis | Litcius